Attached files
| file | filename |
|---|---|
| EX-31.2 - PRINCIPAL FINANCIAL OFFICER CERTIFICATION - SKINOVATION PHARMACEUTICAL INC | f11mar10qexhibit312.htm |
| 10-Q - QUARTERLY REPORT ON FORM 10Q FOR THE PERIOD ENDED MARCH 31, 2011 - SKINOVATION PHARMACEUTICAL INC | skin_11q12.htm |
| EX-31.1 - PRINCIPAL EXECUTIVE OFFICER CERTIFICATION - SKINOVATION PHARMACEUTICAL INC | f11mar10qexhibit311.htm |
Exhibit 32.1
SKINOVATION PHARMACEUTICAL INCORPORATED
CERTIFICATION OF PERIODIC REPORT
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
18 U.S.C. Section 1350
The undersigned executive officer of Skinovation Pharmaceutical Incorporated certifies pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:
a.
the quarterly report on Form 10-Q of Skinovation Pharmaceutical Incorporated for the quarter ended March 31, 2011 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
b.
the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Skinovation Pharmaceutical Incorporated.
Date: April 29, 2011 | /s/ Hugo Rodier Hugo Rodier Principal Executive Officer Principal Financial Officer |